当前位置: X-MOL 学术Clin. Cancer Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer.
Clinical Cancer Research ( IF 11.5 ) Pub Date : 2020-04-01 , DOI: 10.1158/1078-0432.ccr-20-0653
Rabia A. Gilani , Sameer Phadke , Li Wei Bao , Eric J. Lachacz , Michele L. Dziubinski , Kristoffer R. Brandvold , Michael E. Steffey , Frank E. Kwarcinski , Carrie R. Graveel , Kelley M. Kidwell , Sofia D. Merajver , Matthew B. Soellner

[This article][1] ([1][2]) has been retracted at the request of the authors. During their efforts to advance related compounds and analogues, the authors were not able to reproduce the in vivo efficacy results represented in Fig. 5. The authors apologize to the scientific community and deeply regret

中文翻译:

收回:UM-164:一种有效的c-Src / p38激酶抑制剂,对三阴性乳腺癌具有体内活性。

[本文] [1]([1] [2])已应作者要求撤回。在努力推进相关化合物和类似物的过程中,作者无法再现图5所示的体内功效结果。作者向科学界表示歉意,并深表遗憾
更新日期:2020-04-01
down
wechat
bug